Food/Feed and Environmental Risk Assessment of Insect-resistant and Herbicide-tolerant Genetically Modified Maize 59122 x 1507 x NK603 for Food and Feed Uses, Import and Processing under Regulation (EC) No 1829/2003 (EFSA/GMO/UK/2005/21)
Authors: Andreassen Åshild , Brandtzæg Per , Aasmo Finne Merethe , Lorentz Holck Askild , Jevnaker Anne-Marthe , Junttila Olavi , Sjursen Konestabo Heidi , Meadow Richard , Mikalsen Arne , M. Nielsen Kåre , Sanden Monica , Opsahl-Sorteberg Hilde-Gunn , Vikse Rose 
Published: January 2020

In preparation for a legal implementation of EU-regulation 1829/2003, the Norwegian Scientific Committee for Food Safety (VKM) has been requested by the Norwegian Environment Agency (former Norwegian Directorate for Nature Management) and the Norwegian Food Safety Authority (NFSA) to conduct final food/feed and environmental risk assessments for all genetically modified organisms (GMOs) and products containing or consisting of GMOs that are authorized in the European Union under Directive 2001/18/EC or Regulation 1829/2003/EC. The request covers scope(s) relevant to the Gene Technology Act. The request does not cover GMOs that VKM already has conducted its final risk assessments on. However, the Agency and NFSA requests VKM to consider whether updates or other changes to earlier submitted assessments are necessary.

 The insect-resistant and herbicide-tolerant genetically modified maize 59122 x 1507 x NK603 from Pioneer Hi-Bred International, Inc. (Unique Identifier DAS-59122-7 x DAS-Ø15Ø7-1 x MONØØ6Ø3-6) is approved under Regulation (EC) No 1829/2003 for food and feed uses, import and processing since 28 July 2010 (Commission Decision 2010/428/EU). 

 Genetically modified maize 59122 x 1507 x NK603 has previously been risk assessed by the VKM Panel on Genetically Modified Organisms (GMO), commissioned by the Norwegian Food Safety Authority related to the EFSAs public hearing of the application EFSA/GMO/NL/2005/20 in 2007 (VKM 2007a). In addition, 59122 x 1507 x NK603 has been evaluated by the VKM GMO Panel as single events and as a component of several stacked GM maize events (VKM 2004, VKM 2005a,b, VKM 2007b,c, VKM 2008b,c, VKM 2009a,b, VKM 2012).   The food/feed and environmental risk assessment of the maize 59122 x 1507 x NK603 is based on information provided by the applicant in the application EFSA/GMO/UK/2005/21, and scientific comments from EFSA and other member states made available on the EFSA website GMO Extranet. The risk assessment also considered other peer-reviewed scientific literature as relevant.  

 The VKM GMO Panel has evaluated 59122 x 1507 x NK603 with reference to its intended uses in the European Economic Area (EEA), and according to the principles described in the Norwegian Food Act, the Norwegian Gene Technology Act and regulations relating to impact assessment pursuant to the Gene Technology Act, Directive 2001/18/EC on the deliberate release into the environment of genetically modified organisms, and Regulation (EC) No 1829/2003 on genetically modified food and feed. The Norwegian Scientific Committee for Food Safety has also decided to take account of the appropriate principles described in the EFSA guidelines for the risk assessment of GM plants and derived food and feed (EFSA 2011a), the environmental risk assessment of GM plants (EFSA 2010), selection of comparators for the risk assessment of GM plants (EFSA 2011b) and for the post-market environmental monitoring of GM plants (EFSA 2011c).

 The scientific risk assessment of maize 59122 x 1507 x NK603 include molecular characterisation of the inserted DNA and expression of novel proteins, comparative assessment of agronomic and phenotypic characteristics, nutritional assessments, toxicology and allergenicity, unintended effects on plant fitness, potential for gene transfer, interactions between the GM plant and target and non-target organisms, effects on biogeochemical processes. 

 It is emphasized that the VKM mandate does not include assessments of contribution to sustainable development, societal utility and ethical considerations, according to the Norwegian Gene Technology Act and Regulations relating to impact assessment pursuant to the Gene Technology Act. These considerations are therefore not part of the risk assessment provided by the VKM Panel on Genetically Modified Organisms.

 The genetically modified maize stack 59122 x 1507 x NK603 was produced by conventional breeding between inbred lines of maize containing the 59122, 1507 and NK603 events. The hybrid was developed to provide protection against certain lepidopteran and coleopteran target pests, and to confer tolerance to glufosinate-ammonium and glyphosate herbicides.

 Molecular Characterization:

 As conventional breeding methods were used in the production of maize 59122 x 1507 x NK603, no additional genetic modification was involved. Southern and PCR analyses demonstrated that the recombinant insert in the single 59122, 1507 and NK603 events were retained in maize stack 59122 x 1507 x NK603. Genetic stability of the inserts has been demonstrated in the parental lines 59122, 1507 and NK603. Phenotypic analyses demonstrated stability of the insect resistance and herbicide tolerance traits in the hybrid. The expression levels of Cry1F, Cry34Ab1, Cry35Ab1, PAT and CP4 EPSPS proteins in seeds and forage were considered comparable with those in the single events.

 Comparative Assessment:

 The applicant present compositional data on forage and grain material collected from field trials in Europe and North America. Comparative analyses of data from the Europe field trials indicate that maize stack 59122 x 1507 x NK603 is compositionally, agronomically and phenotypically equivalent to its conventional counterpart, with the exception of the introduced insect resistance and herbicide tolerance, conferred by the expression of the Cry1F, Cry34Ab1, Cry35Ab1, PAT               and CP4 EPSPS proteins. In the North American field trials, however, compositional,                 agronomic and phenotypic characteristics of maize 59122 x 1507 x NK603 was compared to a null-segregant comparator. As negative segregants are derived from a GM organism, the VKM GMO Panel does not consider them appropriate conventional counterparts with a history of safe use. Data obtained from field trials with negative segregants are considered as supplementary information only. 

 Based on the assessment of available data, the VKM GMO Panel is of the opinion that conventional crossing of maize 59122, 1507 and NK603 to produce the hybrid 59122 x 1507 x NK603 does not result in interactions that cause compositional, agronomic and phenotypic changes that would raise safety concerns.

 Food and Feed Safety Assessment:

 A poultry feeding study, conducted over a 42-day period, indicated no sub-chronic adverse effects of diets prepared with 59122 x 1507 x NK603 maize. Bioinformatics analyses have not revealed expression of any known ORFs in the parental maize events, and none of the newly expressed proteins showed resemblance to any known toxins or allergens. None of the proteins have been reported to cause IgE mediated allergic reactions. Some studies have, however, indicated a potential role of Cryproteins as adjuvants in allergic reactions.

 Acute and repeated dose toxicity tests in rodents have not indicated toxic effects of the newly expressed proteins. However, these tests do not provide any additional information about possible adverse effects of the stacked event maize 59122 x 1507 x NK603.   Based on the current knowledge, the VKM GMO Panel concludes that 59122 x 1507 x NK603 maize is nutritionally equivalent to its conventional counterpart, and that it is unlikely that the newly expressed proteins introduce a toxic or allergenic potential in food and feed derived from maize 59122 x 1507 x NK603 compared to conventional maize.

 Environmental Risk Assessment:

 The scope of the application EFSA/GMO/UK/2005/21 includes import and processing of maize stack 59122 x 1507 x NK603 for food and feed uses. Considering the intended uses of maize 59122 x 1507 x NK603, excluding cultivation, the environmental risk assessment is concerned with accidental release into the environment of viable grains during transportation and processing, and indirect exposure, mainly through manure and faeces from animals fed grains from maize 59122 x 1507 x NK603.

 Maize 59122 x 1507 x NK603 has no altered survival, multiplication or dissemination characteristics, and there are no indications of an increased likelihood of spread and establishment of feral maize plants in the case of accidental release into the environment of seeds from maize 59122 x 1507 x NK603. Maize is the only representative of the genus Zea in Europe, and there are no crosscompatible wild or weedy relatives outside cultivation. The VKM GMO Panel considers the risk of gene flow from occasional feral GM maize plants to conventional maize varieties to be negligible in Norway. Considering the intended use as food and feed, interactions with the biotic and abiotic environment are not considered by the GMO Panel to be an issue.

 Overall Conclusion:

 The VKM GMO Panel has not identified toxic or altered nutritional properties of maize 59122 x 1507 x NK603 or its processed products compared to conventional maize. Based on current knowledge, it is also unlikely that the newly expressed proteins will increase the allergenic potential of food and feed derived from maize 59122 x 1507 x NK603 compared to conventional maize varieties. 

 The VKM GMO Panel likewise concludes that maize 59122 x 1507 x NK603, based on current knowledge, is comparable to conventional maize varieties concerning environmental risk in Norway with the intended usage.